ADVANCING
ORPHAN ONCOLOGY

TO IMPROVE THE LIFE OF PEOPLE LIVING WITH CANCER BY OFFERING BETTER TREATMENT OPTIONS

OUR STORY

Our Vision

Our vision is to be a leader in identifying, developing and commercializing novel drugs that address unmet needs of people with rare cancer conditions.

 

Learn more about us:

Ascelia Pharma company presentation Dec 2021

Q3-2021 investor conference call

EXHIBITION

RSNA 2021 in Chicago

November 28 – December 2

On 1st December, Dr. Kohkan Shamsi presented the abstract for Orviglance comparison study to gadolinium.

Press release with the study results

RSNA 2021 presentation SSGI12-2 Kohkan Shamsi